Annual Total Long Term Liabilities
$307.17 M
-$1.75 M-0.57%
December 31, 2023
Summary
- As of February 8, 2025, KPTI annual total long term liabilities is $307.17 million, with the most recent change of -$1.75 million (-0.57%) on December 31, 2023.
- During the last 3 years, KPTI annual total long term liabilities has risen by +$104.86 million (+51.84%).
- KPTI annual total long term liabilities is now -1.32% below its all-time high of $311.26 million, reached on December 31, 2021.
Performance
KPTI Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$287.63 M
-$868.00 K-0.30%
September 30, 2024
Summary
- As of February 8, 2025, KPTI quarterly total long term liabilities is $287.63 million, with the most recent change of -$868.00 thousand (-0.30%) on September 30, 2024.
- Over the past year, KPTI quarterly long term liabilities has dropped by -$868.00 thousand (-0.30%).
- KPTI quarterly long term liabilities is now -7.69% below its all-time high of $311.58 million, reached on June 30, 2021.
Performance
KPTI Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
KPTI Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -0.6% | -0.3% |
| 3 y3 years | +51.8% | -7.6% |
| 5 y5 years | +176.4% | +44.8% |
KPTI Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -1.3% | at low | -7.6% | at low |
| 5 y | 5-year | -1.3% | +54.5% | -7.7% | +44.6% |
| alltime | all time | -1.3% | -100.0% | -7.7% | -100.0% |
Karyopharm Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $287.63 M(-0.3%) |
| Jun 2024 | - | $288.50 M(-6.4%) |
| Mar 2024 | - | $308.07 M(+0.3%) |
| Dec 2023 | $307.17 M(-0.6%) | $307.17 M(-0.4%) |
| Sep 2023 | - | $308.28 M(-0.6%) |
| Jun 2023 | - | $310.15 M(+0.2%) |
| Mar 2023 | - | $309.42 M(+0.2%) |
| Dec 2022 | $308.92 M(-0.8%) | $308.92 M(-0.3%) |
| Sep 2022 | - | $309.75 M(-0.2%) |
| Jun 2022 | - | $310.27 M(-0.2%) |
| Mar 2022 | - | $310.77 M(-0.2%) |
| Dec 2021 | $311.26 M(+53.9%) | $311.26 M(+0.0%) |
| Sep 2021 | - | $311.20 M(-0.1%) |
| Jun 2021 | - | $311.58 M(+23.4%) |
| Mar 2021 | - | $252.54 M(+24.8%) |
| Dec 2020 | $202.30 M(+1.7%) | $202.30 M(+0.6%) |
| Sep 2020 | - | $201.19 M(+0.8%) |
| Jun 2020 | - | $199.64 M(-0.3%) |
| Mar 2020 | - | $200.29 M(+0.7%) |
| Dec 2019 | $198.84 M(+78.9%) | $198.84 M(+0.1%) |
| Sep 2019 | - | $198.67 M(+60.9%) |
| Jun 2019 | - | $123.46 M(+1.1%) |
| Mar 2019 | - | $122.07 M(+9.9%) |
| Dec 2018 | $111.12 M | $111.12 M(+1412.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2018 | - | $7.35 M(+11.8%) |
| Jun 2018 | - | $6.57 M(+59.9%) |
| Mar 2018 | - | $4.11 M(+201.5%) |
| Dec 2017 | $1.36 M(-18.2%) | $1.36 M(-5.4%) |
| Sep 2017 | - | $1.44 M(-4.9%) |
| Jun 2017 | - | $1.52 M(-4.7%) |
| Mar 2017 | - | $1.59 M(-4.5%) |
| Dec 2016 | $1.67 M(-14.4%) | $1.67 M(-4.2%) |
| Sep 2016 | - | $1.74 M(-3.8%) |
| Jun 2016 | - | $1.81 M(-3.7%) |
| Mar 2016 | - | $1.88 M(-3.5%) |
| Dec 2015 | $1.95 M(+56.7%) | $1.95 M(+0.4%) |
| Sep 2015 | - | $1.94 M(+3.9%) |
| Jun 2015 | - | $1.87 M(+3.0%) |
| Mar 2015 | - | $1.81 M(+46.0%) |
| Dec 2014 | $1.24 M(>+9900.0%) | $1.24 M(+11.2%) |
| Sep 2014 | - | $1.12 M(+217.3%) |
| Jun 2014 | - | $352.00 K(+107.1%) |
| Mar 2014 | - | $170.00 K(>+9900.0%) |
| Dec 2013 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sep 2013 | - | $99.69 M(>+9900.0%) |
| Jun 2013 | - | $0.00(-100.0%) |
| Dec 2012 | $27.26 M(+53.5%) | $27.26 M |
| Dec 2011 | $17.76 M | - |
FAQ
- What is Karyopharm Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Karyopharm Therapeutics?
- What is Karyopharm Therapeutics annual total long term liabilities year-on-year change?
- What is Karyopharm Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Karyopharm Therapeutics?
- What is Karyopharm Therapeutics quarterly long term liabilities year-on-year change?
What is Karyopharm Therapeutics annual total long term liabilities?
The current annual total long term liabilities of KPTI is $307.17 M
What is the all time high annual total long term liabilities for Karyopharm Therapeutics?
Karyopharm Therapeutics all-time high annual total long term liabilities is $311.26 M
What is Karyopharm Therapeutics annual total long term liabilities year-on-year change?
Over the past year, KPTI annual total long term liabilities has changed by -$1.75 M (-0.57%)
What is Karyopharm Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of KPTI is $287.63 M
What is the all time high quarterly long term liabilities for Karyopharm Therapeutics?
Karyopharm Therapeutics all-time high quarterly total long term liabilities is $311.58 M
What is Karyopharm Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, KPTI quarterly total long term liabilities has changed by -$868.00 K (-0.30%)